EXTEMPORANEOUS COMPOUNDING-Reference-Cited by-同舟云学术

EXTEMPORANEOUS COMPOUNDING

Published:1998-04 Issue:2 Volume:16 Page:321-327
ISSN:0733-8635
Container-title:Dermatologic Clinics
language:en
Short-container-title:Dermatologic Clinics

Author:

Ling Mark R.

Publisher

Elsevier BV

Subject

Dermatology

Reference14 articles.

1. Formulation of dermatologic vehicles;Barry,1983

2. Rheology of dermatological vehicles;Barry,1983

3. The clinical relevance of in vitro investigations for percutaneous absorption;Barry,1985

4. Extemporaneous compounding: Promotional and legal aspects;Fassett;Am Pharmacy,1984

5. Food and Drug Administration Title 21 Code of Federal Regulations. Part 21—Current good manufacturing practice for finished pharmaceuticals. United States.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescribing Pattern of Dermatological Compounding in Ethiopia: The Case of ALERT Hospital;Integrated Pharmacy Research and Practice;2022-01

2. Extemporaneous Compounding Practice for Dermatologic Preparations in Ethiopian Public Hospitals: Regulatory Requirements and Quality Concerns;Risk Management and Healthcare Policy;2021-05

3. Improving Pain Management Knowledge Among Nurses;Medical & Clinical Research;2018-12-04

4. Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 2: Topical Drug Product;Journal of Pharmaceutical Sciences;2015-09

5. Considerations before choosing (extemporaneously) compounded products;Dermatologic Therapy;2009-05